ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Mar 16, 2016
Insider Transaction Report
Form 4
Birner Hubert
Director10% Owner
Transactions
- Purchase
Common Stock
2016-03-14+183,697→ 1,654,788 total(indirect: See Footnote) - Purchase
Common Stock Warrants (right to buy)
2016-03-14+137,773→ 137,773 total(indirect: See Footnote)Exercise: $5.35From: 2016-03-14Exp: 2021-03-14→ Common Stock (137,773 underlying)
Footnotes (2)
- [F1]The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.
- [F2]The reported securities are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which the Reporting Person, Stefan Fischer ("Fischer"), Alexandra Goll ("Goll") and Axel Polack ("Polack"), each a member of the investment committee of TVM V Management, share voting and investment authority over the securities held by TVM V. Each of TVM V Management, the Reporting Person, Fischer, Goll and Polack disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, if any.